Percutaneous cryoablation in the management of spinal metastases: a comprehensive systematic review and meta-analysis - Scorecard - MDSpire

Percutaneous cryoablation in the management of spinal metastases: a comprehensive systematic review and meta-analysis

  • By

  • Mohammad Sadegh Fallahi

  • S. Farzad Maroufi

  • S. Parmis Maroufi

  • MirHojjat Khorasanizadeh

  • Leonardo José Monteiro de Macêdo Filho

  • Konstantinos Margetis

  • Daipayan Guha

  • Claudio E. Tatsui

  • Alireza Mansouri

  • May 13, 2025

  • 0 min

Share

Clinical Scorecard: Cryoablation via percutaneous approach for treating spinal metastases: An extensive systematic review and meta-analysis

At a Glance

CategoryDetail
ConditionSpinal metastases causing severe pain and disability in cancer patients
Key MechanismsPercutaneous cryoablation induces tumor destruction via cycles of freezing and thawing causing cellular dehydration, intracellular ice crystal formation, apoptosis, capillary damage, thrombus formation, and inflammatory response
Target PopulationCancer patients with metastatic spinal tumors, including those with prior radiation therapy and epidural involvement
Care SettingMinimally invasive outpatient procedures guided by CT or MRI, often without general anesthesia

Key Highlights

  • Percutaneous cryoablation (PCA) allows precise tumor targeting with real-time imaging, preserving adjacent vital structures
  • PCA effectively reduces pain by denervating periosteal and tumor-associated nerves, leading to rapid and sustained pain relief and decreased opioid use
  • PCA is a promising alternative or adjunct to conventional radiotherapy and other ablation techniques, especially for frail patients or those with radiation-resistant tumors

Guideline-Based Recommendations

Diagnosis

  • Confirm metastatic spinal tumors via imaging and clinical evaluation prior to PCA
  • Assess tumor location, epidural involvement, and prior treatments including radiation therapy

Management

  • Use percutaneous cryoablation as primary, adjunctive, or salvage treatment for spinal metastases
  • Perform PCA under CT or MRI guidance to ensure precise ablation and minimize damage to spinal cord and adjacent organs
  • Consider PCA for patients unable to tolerate surgery or with radiation-resistant tumors

Monitoring & Follow-up

  • Monitor pain severity scores pre- and post-procedure to assess efficacy
  • Observe for complications such as vascular injury or neural damage
  • Use imaging follow-up to evaluate local tumor control and detect potential adverse effects

Risks

  • Potential for vascular injury and neural damage during ablation
  • Risk of vertebral compression fractures especially after radiotherapy
  • Need for careful patient selection and procedural planning to minimize complications

Patient & Prescribing Data

229 patients with spinal metastases, mean age 61.8 years, 60.6% female, with primary tumors mainly from breast, lung, and thyroid

PCA demonstrated effective local tumor control and significant pain reduction with an average pre-operative pain score of 7.0; majority had prior radiation therapy and lesions commonly located in cervicothoracic spine and vertebral body

Clinical Best Practices

  • Employ multi-probe PCA techniques for comprehensive tumor ablation when appropriate
  • Utilize real-time CT or MRI imaging to guide probe placement and monitor ice ball formation
  • Select patients carefully considering tumor characteristics, prior treatments, and overall health status
  • Incorporate PCA into multimodal pain management strategies to reduce opioid dependence
  • Conduct thorough pre-procedural planning to avoid injury to spinal cord and adjacent organs

References

Original Source(s)

Related Content